Literature DB >> 33762894

The Prevalence of Clinical Features in Patients with Aarskog-Scott Syndrome and Assessment of Genotype-Phenotype Correlation: A Systematic Review.

Victor Zanetti Drumond1, Lucas Sousa Salgado2, Camila Sousa Salgado3, Vitor Augusto de Lima Oliveira4, Eliene Magda de Assis1, Michel Campos Ribeiro5, Analina Furtado Valadão2, Alfredo Orrico6,7.   

Abstract

Aarskog-Scott syndrome is a genetically and clinically heterogeneous rare condition caused by a pathogenic variant in the FGD1 gene. A systematic review was carried out to analyse the prevalence of clinical manifestations found in patients, as well as to evaluate the genotype-phenotype correlation. The results obtained show that clinical findings of the craniofacial, orthopaedic, and genitourinary tract correspond to the highest scores of prevalence. The authors reclassified the primary, secondary, and additional criteria based on their prevalence. Furthermore, it was possible to observe, in accordance with previous reports, that the reported phenotypes do not present a direct relation to the underlying genotypes.
Copyright © 2021 Victor Zanetti Drumond et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33762894      PMCID: PMC7953535          DOI: 10.1155/2021/6652957

Source DB:  PubMed          Journal:  Genet Res (Camb)        ISSN: 0016-6723            Impact factor:   1.588


  35 in total

1.  A mutation in the pleckstrin homology (PH) domain of the FGD1 gene in an Italian family with faciogenital dysplasia (Aarskog-Scott syndrome).

Authors:  A Orrico; L Galli; M Falciani; M Bracci; M L Cavaliere; M M Rinaldi; A Musacchio; V Sorrentino
Journal:  FEBS Lett       Date:  2000-08-04       Impact factor: 4.124

2.  Fraternal twins with Aarskog-Scott syndrome due to maternal germline mosaicism.

Authors:  Laura Pilozzi-Edmonds; Thomas A Maher; Raveen K Basran; Aubrey Milunsky; Khalid Al-Thihli; Nancy E Braverman; Ahmed Alfares
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

3.  Novel FGD1 mutation underlying Aarskog-Scott syndrome with myopathy and distal arthropathy.

Authors:  Abdulaziz Al-Semari; Salma M Wakil; Mohammad A Al-Muhaizea; Mohammed Dababo; Rana Al-Amr; Fowzan Alkuraya; Brian F Meyer
Journal:  Clin Dysmorphol       Date:  2013-01       Impact factor: 0.816

4.  A novel splice site mutation of FGD1 gene in an Aarskog-Scott syndrome patient with a large anterior fontanel.

Authors:  Erhan Parıltay; Filiz Hazan; Esra Ataman; Korcan Demir; Özdal Etlik; Erhan Özbek; Behzat Özkan
Journal:  J Pediatr Endocrinol Metab       Date:  2016-09-01       Impact factor: 1.634

5.  A familial syndrome of short stature associated with facial dysplasia and genital anomalies.

Authors:  D Aarskog
Journal:  J Pediatr       Date:  1970-11       Impact factor: 4.406

6.  Attention-deficit/hyperactivity disorder (ADHD) and variable clinical expression of Aarskog-Scott syndrome due to a novel FGD1 gene mutation (R408Q).

Authors:  Alfredo Orrico; Lucia Galli; Sabrina Buoni; Giuseppe Hayek; Anna Luchetti; Stefania Lorenzini; Michele Zappella; Maria Grazia Pomponi; Vincenzo Sorrentino
Journal:  Am J Med Genet A       Date:  2005-05-15       Impact factor: 2.802

7.  CHIPS for genetic testing to improve a regional clinical genetic service.

Authors:  Y Niida; M Ozaki; M Inoue; E Takase; M Kuroda; Y Mitani; A Okumura; A Yokoi; S Fujita; K Yamada
Journal:  Clin Genet       Date:  2014-09-05       Impact factor: 4.438

8.  Fgd1, the Cdc42 guanine nucleotide exchange factor responsible for faciogenital dysplasia, is localized to the subcortical actin cytoskeleton and Golgi membrane.

Authors:  L Estrada; E Caron; J L Gorski
Journal:  Hum Mol Genet       Date:  2001-03-01       Impact factor: 6.150

9.  Clinical variation of Aarskog syndrome in a large family with 2189delA in the FGD1 gene.

Authors:  Stavit A Shalev; Elana Chervinski; Ehud Weiner; Galia Mazor; Michael J Friez; Charles E Schwartz
Journal:  Am J Med Genet A       Date:  2006-01-15       Impact factor: 2.802

10.  Intelligence and development in Aarskog syndrome.

Authors:  L J Logie; M E Porteous
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

View more
  3 in total

1.  Novel truncating variants in FGD1 detected in two Danish families with Aarskog-Scott syndrome and myopathic features.

Authors:  Allan Bayat; Bjørg Krett; Morten Dunø; Pernille Mathiesen Torring; John Vissing
Journal:  Am J Med Genet A       Date:  2022-04-07       Impact factor: 2.578

2.  FGD1 Variant Associated With Aarskog-Scott Syndrome.

Authors:  Yilin Zhu; Qingqing Chen; Haiyan Lin; Huifei Lu; Yangbin Qu; Qingfeng Yan; Chunlin Wang
Journal:  Front Pediatr       Date:  2022-07-14       Impact factor: 3.569

3.  Case Report: Aarskog-scott syndrome caused by FGD1 gene variation: A family study.

Authors:  Yijia Liang; Honglin Wu; Xiumei He; Xiyu He
Journal:  Front Genet       Date:  2022-08-16       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.